The US Food and Drug Administration (FDA) has approved diclofenac sodium injection (Dyloject, Hospira Inc), a proprietary nonsteroidal anti-inflammatory drug (NSAID) for the treatment of mild to ...
Hospira Receives U.S. FDA Approval of Proprietary Analgesic Dylojectâ„¢(diclofenac sodium) Injection
-- New nonsteroidal anti-inflammatory drug (NSAID) medication used for management of mild to severe pain in adults -- LAKE FOREST, Ill., Dec. 30, 2014 /PRNewswire/ -- Hospira, Inc. (NYSE: HSP), the ...
This study demonstrated that lornoxicam administered as a quick-release formulation is not inferior to the equivalent formulation of diclofenac potassium in terms of onset of PAR in patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results